Work

1248 POSTER A Phase I Study Evaluating GDC-0941, a Pan-phosphoinositide-3 Kinase (PI3K) Inhibitor, in Patients (pts) With Advanced Solid Tumours, Multiple Myeloma, and PIK3Ca Mutant (mt) Tumours

Year: 2011

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(11)70860-7

Authors: S. Banerjee, R. Baird, B. Basu, K. Shah, N. Tunariu, V. Moreno Garcia, J. Corral, K. Mazina, G. Levy, J. de Bono

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2011736254

FWCI: 0.259

Cites:

Cited by: 3

Related to: 10